ArticleBritish journal of cancer2012

Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer.

S Darb-Esfahani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.